US Broker Ratings

Zhengye Biotechnology Holding L (ZYBT): Navigating Challenges with a Focus on Veterinary Vaccines in China

Investors in the healthcare sector might find Zhengye Biotechnology Holding L (ZYBT) an intriguing yet challenging prospect due to its niche focus on veterinary vaccines. Based in Jilin, China, the..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 173% Potential Upside with Innovative Hemodialysis Solutions

Outset Medical, Inc. (OM), a promising player in the medical devices sector, might just be the opportunity investors are looking for, given its substantial potential upside of 173.44%. Specializing in..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Unpacking the 173.52% Potential Upside Amidst Robust Revenue Growth

ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering entity in the healthcare sector, is making waves in the medical devices industry with its innovative platform for minimally invasive brain surgeries. With..

Rigel Pharmaceuticals, Inc. (RIGL): Investor Outlook with 86% Potential Upside

For investors seeking opportunities in the biotechnology sector, Rigel Pharmaceuticals, Inc. (RIGL) offers a compelling prospect with its impressive potential upside of 86.18%. The company, headquartered in South San Francisco,..

TotalEnergies SE (TTE) Stock Analysis: Balancing a Robust Dividend Yield with Modest Growth Potential

TotalEnergies SE (NYSE: TTE), a major player in the integrated oil and gas sector, offers a compelling proposition for investors seeking exposure to the energy market with a robust dividend..

NANO-X IMAGING LTD (NNOX) Stock Analysis: Potential 207% Upside Sparks Investor Interest

For investors keeping a keen eye on the healthcare sector, particularly the medical devices industry, Nano-X Imaging Ltd. (NASDAQ: NNOX) stands out as a compelling opportunity. Based in Israel, this..

Erasca, Inc. (ERAS) Stock Analysis: A Promising Biotech with Analyst Consensus and Growth Potential

Erasca, Inc. (ERAS), a clinical-stage biotechnology company, is gaining traction in the healthcare sector with its focus on precision oncology. Specializing in the development of therapies targeting RAS/MAPK pathway-driven cancers,..

Mereo BioPharma Group (MREO) Stock Analysis: Unpacking a 423% Potential Upside

For investors with a keen interest in the biotechnology sector, Mereo BioPharma Group plc (NASDAQ: MREO) presents a fascinating opportunity. This London-based biopharmaceutical company, with a market capitalization of $52.67..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 52.83% Potential Upside in Bioelectric Medicine

Investors seeking opportunities in the burgeoning healthcare sector might find Pulse Biosciences, Inc. (NASDAQ: PLSE) a compelling consideration. With its innovative approaches in bioelectric medicine and a significant potential upside,..

MannKind Corporation (MNKD) Stock Analysis: Exploring a Potential 216% Upside in the Biotech Space

MannKind Corporation (MNKD), a pivotal player in the biotechnology sector, presents an intriguing investment opportunity with a potential upside of 216.46%, according to analyst ratings. Specializing in groundbreaking solutions for..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 70% Potential Upside in a Challenging Market

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the medical devices sector, presents a compelling case for investors willing to navigate its current challenges in pursuit of significant..

10x Genomics, Inc. (TXG): Analyzing the Growth Potential and Market Position in Healthcare Innovation

As a leader in health information services, 10x Genomics, Inc. (NASDAQ: TXG) is at the forefront of transforming biological research through its cutting-edge technologies. With a market capitalization of $2.53..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 23.40% Upside Potential in the Healthcare Sector

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands out in the healthcare sector as a key player in the development and distribution of non-opioid pain management solutions. With a market capitalization of..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Firm with Potential 300% Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is catching the attention of investors with its innovative approach to RNA medicine and a staggering potential upside of..

Evolent Health, Inc (EVH) Valuation Insights: Analyzing a Potential 138% Upside

Evolent Health, Inc. (EVH) stands at a pivotal juncture, with investors keenly eyeing its potential for substantial upside. As a player in the healthcare sector, specifically within the health information..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 90.95% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) has captured the attention of investors with its significant potential upside of 90.95%, as indicated by analyst ratings. Operating within the healthcare sector, specifically in the..

Kestra Medical Technologies (KMTS) Stock Analysis: Unpacking a 56.65% Potential Upside in Healthcare Innovation

Investors with an eye on the healthcare sector may want to take note of Kestra Medical Technologies, Lt (KMTS), a burgeoning player in the medical instruments and supplies industry. Based..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a 125% Potential Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing investor attention in the biotechnology sector with its promising pipeline of innovative therapies aimed at treating serious and rare diseases. With a market..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A 110% Upside Potential Beckons Investors

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is catching the eye of investors with its promising pipeline and a notable 110% potential upside. This Radnor, Pennsylvania-based biopharmaceutical company is spearheading innovative treatments..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 28.34% Potential Upside for Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG), a notable player in the medical care facilities industry, offers an intriguing investment opportunity with a potential upside of 28.34%. As of the latest..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds